Therapeutic Half-Cell for Selective Electron Transfer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for therapeutic electron and ion transfer to or from organisms are limited in their ability to selectively provide antioxidant or prooxidant effects, leading to inefficiencies in managing free radical damage, and existing technologies lack precision in targeting specific areas within an organism.
Innovation Solution
The development of a therapeutic device utilizing a half-cell with ionically and electrically conductive paths for selective electron transfer, featuring an active material that can act as an oxidizing or reducing agent, allowing for controlled electron transfer between the device and an organism, thereby achieving a net transfer of electrons to or from the organism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antioxidants are used as nutritional supplements to prevent oxidative stress, then cellular protection is improved, but high levels can be toxic and the effects are diffuse rather than targeted
Solution Approach 1:
The patent applies local quality by enabling targeted delivery of electrons to specific tissues or organs through externally applied electrodes, rather than systemic distribution through supplements. The electron transfer device allows localized antioxidant or prooxidant effects at the application site, providing precise spatial control over where electron transfer occurs in the body.
Solution Approach 2:
The patent utilizes parameter changes by controlling the direction and magnitude of electron transfer through adjustable electrical parameters. By varying the electrical potential applied through the half-cell device, the system can switch between providing electrons (antioxidant effect) and withdrawing electrons (prooxidant effect), thereby dynamically controlling the therapeutic outcome without changing the fundamental mechanism.
2Reliability
If prooxidants are used to show toxicity toward cancer cells, then cancer cell destruction is improved, but prooxidants are generally harmful to the body and high levels cause oxidative stress
Solution Approach 1:
The patent applies local quality by concentrating the prooxidant electron-withdrawing effect only at the tumor site through localized electrode placement. This allows selective destruction of cancer cells through oxidative stress induced only in the targeted region, while the rest of the body remains protected from systemic oxidative damage.
Solution Approach 2:
The patent utilizes segmentation by dividing the treatment into localized zones - the tumor region receives electron withdrawal (prooxidant effect) while other body regions can receive electron donation (antioxidant protection) or remain unaffected. This spatial segmentation allows simultaneous or alternating treatment of different body regions with opposite electron transfer directions.
3Reliability
If electron transfer is applied to treat specific conditions, then therapeutic efficacy is improved, but precision in targeting specific areas within an organism is limited
Solution Approach 1:
The patent applies local quality through the use of surface electrodes positioned on the skin over specific organs or tissues. The electron transfer is localized to the underlying tissue beneath the electrode contact points, allowing precise targeting of specific body regions. The half-cell configuration ensures that electron transfer occurs only at the electrode-tissue interface, providing spatial precision.
4Reliability
If a full electrochemical cell is used for electron transfer, then electron transfer capability is improved, but device complexity increases due to need for both anode and cathode
Solution Approach 1:
The patent applies the extraction principle by taking only the essential half-cell component needed for electron transfer and applying it to the patient's body. The external environment (body fluids, tissues, and atmospheric oxygen) serves as the other half of the electrochemical cell, eliminating the need to transport and apply a complete sealed electrochemical cell. This reduces device complexity while maintaining electron transfer capability.
Solution Approach 2:
The patent utilizes universality by designing a simple electrode interface that can function in multiple roles - as an electron source when connected to a reducing agent, or as an electron sink when connected to an oxidizing agent. The half-cell device can be adapted for different therapeutic applications (antioxidant or prooxidant) by changing the chemical composition of the electrolyte or active material, providing multi-functionality without increasing structural complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables precise modulation of free radical damage by selectively providing antioxidant or prooxidant effects, allowing for targeted therapeutic interventions within an organism, enhancing the efficacy of treatments for conditions associated with oxidative stress.
Implementation Method 1
The active material includes an oxidizing agent or a reducing agent. When the active material is an oxidizing agent, the therapeutic device withdraws electrons from the organism. When the active material is a reducing agent, the therapeutic device provides electrons to the organism.
Implementation Method 2
one or more ionically conductive paths for ion transfer between the organism and the half-cell
Data Source
AI summary
A therapeutic electron transfer device including a half-cell and an ionically conductive path for ion transfer between an organism and the half-cell. The half-cell includes an electrically conductive electrode, an active material in contact with the electrode, and an electrically conductive path for electron transfer between the organism and the electrode. The active material includes an oxidizing agent or a reducing agent, such that electron transfer occurs spontaneously from or to the organism, respectively. A kit includes therapeutic electron transfer device and instructions for use. Two therapeutic electron transfer devices may be used simultaneously or alternately to provide electrons to an organism, withdraw electrons from an organism, or both.